Are we still in a golden age for biotech investing? Join the discussion at noon.
admin Are we still in a golden age for biotech investing? Join the discussion at noon.
Read MoreBiotech
Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech
Shares of Imago BioSciences Inc. IMGO, -3.87% soared toward an eight-month high in premarket trading…
Read MoreModerna stock slides 14% premarket after profit and revenue fall short of estimates and biotech offers soft guidance
Moderna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine…
Read MoreBio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in…
Read MoreInvestors piling into health-care ETFs points to defensive bets, ‘bottom-fishing’ in biotech
Hello! In this week’s ETF Wrap, health-care ETFs take the spotlight as investors get defensive…
Read MoreMerck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and…
Read MoreAn Information Technology Consulting Company That Is Perfect for a Biotech Firm – 7 Signs
Small and midsize Biotech companies do not have the financial resources that their larger pharmaceutical…
Read More